Telix Pharmaceuticals (TLX) EBITDA (2011 - 2025)
Telix Pharmaceuticals (TLX) EBITDA from Jun 30, 2011 to Dec 31, 2025. The TTM Telix Pharmaceuticals (TLX) EBITDA is $99M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Telix Pharmaceuticals (TLX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -66.16% |
| 10 Years TTM | +39.36% |
| All Time TTM | +35.50% |
Annual EBITDA change of Telix Pharmaceuticals (TLX)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | $53M | -12.36% |
| 2024 | $61M | +288.73% |
| 2023 | $16M | -124.77% |
| 2022 | -$63M | +24.14% |
| 2021 | -$51M | +47.02% |
| 2020 | -$35M | +101.34% |
| 2019 | -$17M | -5.63% |
| 2018 | -$18M | +336.75% |
| 2017 | -$4.17M | +57804.97% |
| 2016 | -$7.20K | -50.64% |
| 2015 | -$15K | -98.72% |
| 2014 | -$1.14M | -178.18% |
| 2013 | $1.46M | +72.72% |
| 2012 | $846K | -81.66% |
| 2011 | $4.61M | N/A |